SILK News and Press, Silk Road Medical Inc. From 11/08/22

Silk Road Medical press release ( NASDAQ: SILK ): Q3 GAAP EPS of -$0.29 beats by $0.14 . Revenue of $37.4M (+51.4% Y/Y) beats by $3.76M . Cash, cash equivalents and short-term investments were $105.1 million as of September 30, 2022. Gross profit for the th...

SUNNYVALE, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2022. “Our performance in the thir...

SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences. Stifel 2022 He...

SUNNYVALE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2022 after market close on Tuesday, November 8 t...

Silk Road Medical ( NASDAQ: SILK ) prices an underwritten public offering of 2,325,582 shares of its common stock at a public offering price of $43.00/share. Underwriters are granted a 30-day option to purchase up to an additional 348,837 shares of common stock at the publ...

SUNNYVALE, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an underwritten public offering of 2,325,582 shares of its common stock at a public offeri...

Silk Road Medical ( NASDAQ: SILK ) stock dropped 6.3% after hours on Monday after the firm announced preliminary estimates of certain metrics as of the end of Q3. The company estimates revenue of $37.4M, as compared to $24.7M for the three months ended S...

SUNNYVALE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced certain preliminary financial data for the quarter ended September 30, 2022. Summary Preliminary ...

Silk Road Medical ( NASDAQ: SILK ) has commenced a proposed underwritten public offering of $100M of shares of its common stock. Additionally, the Co. expects to grant the underwriters a 30-day option to purchase additional shares of common stock in an amount of up to 15% ...

SUNNYVALE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced enrollment of the first patient in ROADSTER 3, the first prospective, multi-center, single-arm st...